Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2.
about
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsDetermination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line.Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivo.Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 geneAssessment of Pharmacodynamic and Pharmacokinetic Interaction of Aqueous Extract of Cassia auriculata L. and Metformin in Rats.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes.Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials.Sustained drug-delivery system: a promising therapy for denture stomatitis?Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin.
P2860
Q28072205-EA094DB1-E1C6-4C06-A9ED-A9453A93D0B1Q34264069-605BCDC6-C9DC-43E1-8BC4-3824C0542EC5Q35039323-49FF561D-C6D4-4F2C-AD7D-37129FEF6FBFQ35187890-556051F2-CB4B-4A69-9E8B-F1CAD81472A7Q35489261-4425430C-7B9B-4ABB-8D80-557A62894E9CQ38282223-95BA8A3C-A821-4BF1-A04F-B827A9E4DAD3Q38696236-AF2D7E0A-C4E2-4464-8B17-2233B2B8600BQ39379908-78AD2170-07A8-4ECB-855F-B9B2C35C6034Q40211768-6B5DAF6E-5A2D-4B39-AC04-735F87DD8916Q42379357-1ED4CA43-E074-47DF-9FE2-4244D772A528Q50904722-17C0E51E-88AD-42E5-B713-8796274C2729Q51076455-07939D79-CC54-42FB-AC7F-335AE35A243C
P2860
Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@ast
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@en
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@nl
type
label
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@ast
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@en
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@nl
prefLabel
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@ast
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@en
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@nl
P2093
P2860
P1476
Pharmacokinetic interaction be ...... patic and intestinal CYP3A1/2.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2010.00913.X
P407
P577
2010-10-01T00:00:00Z